Projects (582)
Cardiff University Schools involved in this Project
Pharmacy practice and pharmaceutical public health (01/08/1997 - 04/03/2011)
- Baxter, Gary
Advanced drug delivery (GALENOS) (01/10/2004 - 30/09/2008)
- Gumbleton, Mark
Research into aspects of cancer (01/01/2005 - 31/03/2012)
- Mcguigan, Christopher
Pharmacy practice development 1 (14/03/2005 - 14/03/2008)
Pharmacy practice development (14/03/2005 - 31/03/2010)
Sugar phosphates for osteoarthritis (01/11/2005 - 16/11/2009)
- Mcguigan, Christopher
Evaluation of pharmacological activities (01/08/2006 - 31/10/2009)
Bioresponsive polymer-peptide conjugates for enhanced intracellular delivery of macromolecules (20/09/2006 - 19/06/2010)
- Jones, Arwyn
Inhibition of b-secretase by antibodies to amyloid precursor protein - a novel therapy for Alzheimer's disease (01/10/2006 - 31/03/2010)
- Kidd, Emma
Synthesis of novel indole derivatives as apoptosis-inducing antitumour agents (01/01/2007 - 01/01/2010)
- Westwell, Andrew
Deciphering of compensatory signalling promoted by targeted theraphies in breast cancer (01/04/2007 - 30/09/2010)
Cell penetrating peptides (02/04/2007 - 02/04/2010)
- Jones, Arwyn
MRSA bacteriophage therapy (01/06/2007 - 31/12/2007)
The role of bacterial toxins in diabetes (01/07/2007 - 30/06/2010)
- Wann, Kenneth
Parenteral nutrition and drug stability (01/09/2007 - 31/08/2012)
- Cosslett, Allan
Microneedle based immunization against pandemic influenza (07/09/2007 - 11/02/2013)
- Birchall, James
Cancer drug discovery: Targeting protein - protein interactions (01/10/2007 - 01/10/2010)
- Westwell, Andrew
Detection of lipopolysaccharide pyrogens by molecularly-imprinted polymers (01/10/2007 - 30/09/2010)
Formulation effects in anti-microbial activity - Nor Hayati Binti Abu Samah (01/10/2007 - 30/09/2010)
- Heard, Charles
Isolation and chemical and pharmacological characterization of potentional trace amine receptor antagonists from plant sources (01/10/2007 - 28/02/2011)
Towards a nanomedicine-based broad-spectrum topical virucidal therapeutic system (01/10/2007 - 31/01/2011)
- Heard, Charles
The contribution of the exosporium of bacillus anthracis to survival (ROLEEXOSPORIUM) (01/11/2007 - 31/12/2010)
- Baillie, Les
Anti-HCV Nucleosides (15/11/2007 - 09/10/2013)
- Mcguigan, Christopher
Development of cannabrinoid conjugates for the treatment of intestinal inflammation (01/01/2008 - 31/12/2010)
- Ford, William
Role of Rho-dependent kinase in mediating reperfusion injury (07/01/2008 - 17/06/2010)
- Baxter, Gary
Investigation of insulin receptor substrate-1 (IRS-1) as a signalling intermediate for erbB receptors in breast cancer (01/02/2008 - 31/01/2011)
- Hutcheson, Iain
Access to Phrmy labs (01/04/2008 - 31/10/2011)
Development of CYP26 inhibitors as neuroblastoma therapeutics (01/07/2008 - 31/03/2011)
- Simons, Claire
Understanding the interactions of oxidising agents with macromolecules and microbial cell components (01/07/2008 - 01/07/2011)
- Maillard, Jean-Yves
Serotonin associated injury and survival signalling in myocardium: Receptor dependant and non receptor targets for cytoprotection (01/09/2008 - 18/11/2012)
- Baxter, Gary
Studies on the exacerbation of pulmonary inflammation by viral infection (01/09/2008 - 31/01/2012)
- Ford, William
To examine the action of R 1507 in a range of breast cancer models reflective of endocrine response and failure (01/09/2008 - 31/03/2010)
- Hutcheson, Iain
An assessment using conventional polymer moulding techniques, of sugars, cyclodextrins and natural polyerms for biodegradable microneedle applications (01/10/2008 - 01/07/2012)
- Birchall, James
Anticancer drug discovery (01/10/2008 - 01/06/2010)
- Mcguigan, Christopher
Discover antiviral carbohydrate binding agents (01/10/2008 - 31/12/2013)
- Mcguigan, Christopher
A real time, stand alone, portable detector for Bacillus anthracis spores (01/01/2009 - 01/04/2009)
- Baillie, Les
Pulmonary pharmacokientics of antimicrobial peptides (12/01/2009 - 12/01/2010)
- Gumbleton, Mark
Meeting - Preservatives in gaviscon formulations (26/01/2009 - 10/02/2010)
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (01/03/2009 - 13/01/2010)
- Maillard, Jean-Yves
Evaluation of rapid microbial detection methods to improve the quality assurance release process for NHS aseptic manufactured products (02/03/2009 - 25/12/2009)
- Maillard, Jean-Yves
Consultancy to advise on the analysis of anthelminthic drug when co-formulated with nutritional supplements (16/03/2009 - 16/06/2009)
- Allender, Christopher
Biomaterials and biological interfaces: Towards optimising drug gene delivery (01/04/2009 - 31/08/2010)
- Gumbleton, Mark
Combined use of AZD0530 and fulvestrant in breast cancer (01/04/2009 - 31/03/2010)
- Hiscox, Stephen
Pilot markers study in breast cancer to assess treatment failure to targeted therapies (01/04/2009 - 31/03/2011)
Anti_CD44 antibody in breast cancer cell lines (01/05/2009 - 01/11/2009)
- Hutcheson, Iain
Investigation of mTOR inhibition using AZ5 in breast cancer models responsive and resistant to oestrogen deprivation in vitro (01/05/2009 - 31/12/2011)
- Gee, Julia
PHARMATRAIN - Pharmaceutical medicine training programmes (01/05/2009 - 30/04/2014)
Topical delivery of Melatonin Derivatives (01/06/2009 - 30/09/2009)
- Heard, Charles
Characterisation of the immune response to the AVP vaccine (01/07/2009 - 28/02/2010)
- Baillie, Les
Device testing (01/07/2009 - 31/05/2010)
- Birchall, James
Roles of trace amine associated receptors in cardiovascular responses to dietary trace amines (01/08/2009 - 30/04/2013)
- Ford, William
Anti-cancer protides (21/08/2009 - 31/12/2015)
- Mcguigan, Christopher
Role of HER2/HER3, other signalling pathways and the ability of AZD8931 to inhibit the growth of EGFR responsive anti-hormone-resistant breast cancer lines (01/09/2009 - 31/03/2012)
Endocytosis of carbohydrate based drug conjugates (14/09/2009 - 30/06/2010)
- Jones, Arwyn
An antibody based theraphy for Clostridium difficile (01/10/2009 - 30/09/2011)
- Baillie, Les
Mechanisms of resistance to steroid actions in the airways (01/10/2009 - 01/10/2012)
Model of intent in crowded places (01/10/2009 - 31/03/2010)
- Baillie, Les
Small molecule inhibitors of CYP24A1 - Prostate cancer therapeutics (01/10/2009 - 30/09/2013)
- Simons, Claire
Development of new agents for colorectal cancer (CRC) using genetically defined autochthonous models (01/11/2009 - 31/10/2011)
- Mcguigan, Christopher
Development of new ANTIVIRAL agents for cytomegalovirus and smallpox infection (01/11/2009 - 31/10/2011)
- Mcguigan, Christopher
Comparison of the bronchodiator activity of novel compounds (09/11/2009 - 31/01/2010)
International Society for Zinc Biology 2009 Meeting (30/11/2009 - 31/01/2010)
- Taylor, Kathryn
Fulvestrant/aromatase inhibitor treatment of clinical breast cancer steroid receptor and proliferation biomarker research study (01/12/2009 - 30/11/2010)
- Gee, Julia
Efficacy of pharmacological agents against piv-3 induced steroid resistance asthma (01/01/2010 - 31/12/2010)
- Ford, William
KESS - Knowledge economy skills scholarship (01/01/2010 - 31/07/2015)
- Baillie, Les
PhD studentship, Abjullah Sahib A Alsherhri (01/01/2010 - 31/12/2012)
- Baxter, Gary
Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for position emission tomography (PET) imaging (01/01/2010 - 01/01/2013)
- Westwell, Andrew
Preliminary investigation of drug efficacy against ovalbumin-induced airway inflammation (01/02/2010 - 30/11/2010)
- Ford, William
The sporicidal activity of phoraid against Bacillus anthracis spores (01/02/2010 - 26/03/2010)
- Baillie, Les
Testing of the sporicidal activity of 10 commercially available wipes against clostridium difficile (29/03/2010 - 30/09/2011)
- Maillard, Jean-Yves
Examination of the adhesion molecule CD44 and its variants in relation to endocrine treatment outcome in clinical breast cancer (01/04/2010 - 31/08/2018)
- Gee, Julia
Tissue engineering for human healing (12/04/2010 - 13/10/2011)
- Jones, Arwyn
Evaluation of a community pharmacy based cardiovascular risk assessment service (26/04/2010 - 25/10/2011)
- John, Dai
The sporicidal activity of formalin, hydrogen peroxide, peracetic acid and bleach against Bacillus anthracis spores (01/06/2010 - 31/03/2011)
- Baillie, Les
To carry out experiments to investigate the diffusion of budesonide across ocular membranes (01/06/2010 - 31/05/2012)
- Allender, Christopher
Understanding the biomechanics of human skin tissue and micro-disruption of the skin barrier by transdermal delivery systems (TDS), such as the microneedle array device (MD) (01/06/2010 - 31/05/2011)
- Coulman, Sion
To embed expertise on the development of novel biochemical reagents to pathogens and exploit this knowledge to develop point-of-care products for the healthcare sector (07/06/2010 - 06/06/2012)
- Baillie, Les
The role of zinc transporters in cellular zinc signalling (01/08/2010 - 19/09/2015)
- Taylor, Kathryn
Antimicrobial resistance test development (01/10/2010 - 22/06/2012)
- Maillard, Jean-Yves
Biocide impregnated surface materials for use in clinical areas - under what conditions do they work? (01/10/2010 - 30/09/2015)
- Maillard, Jean-Yves
Discovery of novel HCV helicas inhibitors (01/10/2010 - 30/09/2012)
- Brancale, Andrea
Identification and validation of method(s) to describe antimicrobial resistance development (01/10/2010 - 30/09/2013)
- Maillard, Jean-Yves
Inducing tyrosine kinase receptor degradation as a novel therapeutic strategy in breast cancer (01/10/2010 - 31/12/2014)
- Jones, Arwyn
Resistance mechanisms during prolonged antihormone exposure (01/10/2010 - 31/03/2016)
- Gee, Julia
Evaluation of the ability of current and novel environmentally friendly biocides to remediate anthrax spore contaminated environments (01/11/2010 - 31/03/2012)
- Baillie, Les
Molecular modelling on guanlib analogues (01/11/2010 - 31/10/2011)
- Brancale, Andrea
The role of caveolins in the processing of amyloid precursor protein (01/11/2010 - 29/02/2012)
- Kidd, Emma
The therapeutic potential of focal adhesion kinase in endocrine-responsive/resistant breast cancer and the HER2+breast cancer subtype (01/11/2010 - 31/07/2012)
- Hiscox, Stephen
Visualisation of biocide effect against Salmonella spp (08/11/2010 - 07/12/2010)
- Maillard, Jean-Yves
A natural therapy for bovine tuberculosis and greenhouse gases (01/01/2011 - 31/12/2013)
- Baillie, Les
An evaluation of outcomes reported by patients with focal hyperhidrosis treated with methanthelinium bromide to support it's reimbursement policy (01/01/2011 - 31/12/2012)
Preclinical study of Vandetanib in breast cancer (01/01/2011 - 31/08/2015)
- Gee, Julia
Advice on formulations (01/03/2011 - 31/03/2011)
- Maillard, Jean-Yves
EUVIRNA - European training network on (+)rna virus replication and antiviral drug development (01/03/2011 - 28/02/2015)
- Mcguigan, Christopher
HIPODERM - High potency dermatologicals (01/03/2011 - 28/02/2015)
- Allender, Christopher
PheVec: A universal strategy for enhancing the therapeutic delivery capacity of cell penetrating peptides (01/04/2011 - 31/05/2012)
- Jones, Arwyn
Serology assays of serum samples (01/04/2011 - 31/05/2012)
- Baillie, Les
Developing sporicidal formulations (23/05/2011 - 22/05/2013)
- Maillard, Jean-Yves
Evaluating the potential for patient application of a microneedle device (02/06/2011 - 30/11/2011)
- Coulman, Sion
Determining in vitro whether magnesium penetrates skin (01/07/2011 - 30/09/2011)
- Heard, Charles